Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07516353
What this trial is testing

My.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Who this might be right for
SarcomaOsteosarcomaEwing Sarcoma+6 more
Dana-Farber Cancer Institute 143
Early research (Phase 1)Ended earlyNCT01849276
What this trial is testing

Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more
Northwestern University 2
Testing effectiveness (Phase 2)Study completedNCT02666950
What this trial is testing

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Isolated Del(5q)Myelodysplastic/Myeloproliferative Neoplasm+3 more
Mayo Clinic 3
Early research (Phase 1)Study completedNCT00692926
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

Who this might be right for
MDSAnemia, AplasticInborn Errors of Metabolism+2 more
Joanne Kurtzberg, MD 37
Early research (Phase 1)Ended earlyNCT01204450
What this trial is testing

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma+1 more
UNC Lineberger Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)WithdrawnNCT04483414
What this trial is testing

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Metastatic to Bone
Dana Mathews
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Not applicableStudy completedNCT05709158
What this trial is testing

Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

Who this might be right for
Breast Cancer
Pfizer 4,184
Not applicableLooking for participantsNCT00816114
What this trial is testing

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 3,000
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Large-scale testing (Phase 3)Study completedNCT01951885
What this trial is testing

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more
Case Comprehensive Cancer Center 101
Not applicableStudy completedNCT03907774
What this trial is testing

MPN Podcast Pilot Study

Who this might be right for
Myeloproliferative Neoplasm, Unclassifiable
Arizona State University 39
Testing effectiveness (Phase 2)Ended earlyNCT00708721
What this trial is testing

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Who this might be right for
CancerChronic Myelomonocytic Leukemia
University of Utah 11
Not applicableStudy completedNCT06159816
What this trial is testing

PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES

Who this might be right for
Myeloproliferative Neoplasm
AUSL Romagna Rimini 300
Not applicableStudy completedNCT01250314
What this trial is testing

Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density

Who this might be right for
Osteoporosis
Assistance Publique - Hôpitaux de Paris 79
Testing effectiveness (Phase 2)Study completedNCT01005043
What this trial is testing

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
University Hospital Heidelberg 23
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Testing effectiveness (Phase 2)UnknownNCT04578847
What this trial is testing

REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia in RemissionBCR-ABL Positive Chronic Myelogenous Leukemia
National Research Center for Hematology, Russia 100
Early research (Phase 1)Study completedNCT00827138
What this trial is testing

Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)

Who this might be right for
Chronic Myeloid Leukemia
Deciphera Pharmaceuticals, LLC 57
Early research (Phase 1)Study completedNCT00132158
What this trial is testing

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
GlioblastomaRhabdomyosarcomasNeuroblastoma+1 more
St. Jude Children's Research Hospital 19
Next Page